Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Goldschmidt, Hartmut (VerfasserIn) , Sonneveld, P. (VerfasserIn) , Cremer, Friedrich Walter (VerfasserIn) , Holt, B. van der (VerfasserIn) , Westveer, P. (VerfasserIn) , Breitkreutz, Iris (VerfasserIn) , Benner, Axel (VerfasserIn) , Glasmacher, A. (VerfasserIn) , Schmidt-Wolf, I. G. D. (VerfasserIn) , Martin, H. (VerfasserIn) , Hoelzer, D. (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Lokhorst, H. M. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 July 2003
In: Annals of hematology
Year: 2003, Jahrgang: 82, Heft: 10, Pages: 654-659
ISSN:1432-0584
DOI:10.1007/s00277-003-0685-2
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00277-003-0685-2
Volltext
Verfasserangaben:H. Goldschmidt, P. Sonneveld, F.W. Cremer, B. van der Holt, P. Westveer, I. Breitkreutz, A. Benner, A. Glasmacher, I. G.D. Schmidt-Wolf, H. Martin, D. Hoelzer, A.D. Ho, H.M. Lokhorst

MARC

LEADER 00000caa a2200000 c 4500
001 1789433827
003 DE-627
005 20220820125520.0
007 cr uuu---uuuuu
008 220211s2003 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00277-003-0685-2  |2 doi 
035 |a (DE-627)1789433827 
035 |a (DE-599)KXP1789433827 
035 |a (OCoLC)1341441681 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
245 1 0 |a Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients  |c H. Goldschmidt, P. Sonneveld, F.W. Cremer, B. van der Holt, P. Westveer, I. Breitkreutz, A. Benner, A. Glasmacher, I. G.D. Schmidt-Wolf, H. Martin, D. Hoelzer, A.D. Ho, H.M. Lokhorst 
264 1 |c 4 July 2003 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.02.2022 
700 1 |a Sonneveld, P.  |e VerfasserIn  |4 aut 
700 1 |a Cremer, Friedrich Walter  |d 1967-  |e VerfasserIn  |0 (DE-588)115550461  |0 (DE-627)691396221  |0 (DE-576)289943752  |4 aut 
700 1 |a Holt, B. van der  |e VerfasserIn  |4 aut 
700 1 |a Westveer, P.  |e VerfasserIn  |4 aut 
700 1 |a Breitkreutz, Iris  |d 1970-  |e VerfasserIn  |0 (DE-588)124783309  |0 (DE-627)366051806  |0 (DE-576)186798725  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Glasmacher, A.  |e VerfasserIn  |4 aut 
700 1 |a Schmidt-Wolf, I. G. D.  |e VerfasserIn  |4 aut 
700 1 |a Martin, H.  |e VerfasserIn  |4 aut 
700 1 |a Hoelzer, D.  |e VerfasserIn  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Lokhorst, H. M.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of hematology  |d Berlin : Springer, 1991  |g 82(2003), 10, Seite 654-659  |h Online-Ressource  |w (DE-627)253389852  |w (DE-600)1458429-3  |w (DE-576)072283157  |x 1432-0584  |7 nnas  |a Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients 
773 1 8 |g volume:82  |g year:2003  |g number:10  |g pages:654-659  |g extent:6  |a Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients 
856 4 0 |u https://doi.org/10.1007/s00277-003-0685-2  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220211 
993 |a Article 
994 |a 2003 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |p 7 
998 |g 124783309  |a Breitkreutz, Iris  |m 124783309:Breitkreutz, Iris  |d 910000  |d 910100  |e 910000PB124783309  |e 910100PB124783309  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 115550461  |a Cremer, Friedrich Walter  |m 115550461:Cremer, Friedrich Walter  |d 910000  |d 910100  |e 910000PC115550461  |e 910100PC115550461  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1789433827  |e 4055997035 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"6 S."}],"name":{"displayForm":["H. Goldschmidt, P. Sonneveld, F.W. Cremer, B. van der Holt, P. Westveer, I. Breitkreutz, A. Benner, A. Glasmacher, I. G.D. Schmidt-Wolf, H. Martin, D. Hoelzer, A.D. Ho, H.M. Lokhorst"]},"recId":"1789433827","relHost":[{"language":["eng"],"titleAlt":[{"title":"Hematology"}],"part":{"issue":"10","text":"82(2003), 10, Seite 654-659","year":"2003","pages":"654-659","volume":"82","extent":"6"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"253389852","id":{"issn":["1432-0584"],"zdb":["1458429-3"],"eki":["253389852"]},"title":[{"title":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title_sort":"Annals of hematology"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedDisp":"1991-","dateIssuedKey":"1991","publisher":"Springer"}],"pubHistory":["62, 1 (Februrary 1991)-"],"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsAnnals of hematology"}],"id":{"eki":["1789433827"],"doi":["10.1007/s00277-003-0685-2"]},"title":[{"title":"Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients","title_sort":"Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients"}],"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"4 July 2003"}],"note":["Gesehen am 11.02.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"given":"P.","role":"aut","display":"Sonneveld, P.","family":"Sonneveld"},{"display":"Cremer, Friedrich Walter","family":"Cremer","given":"Friedrich Walter","role":"aut"},{"display":"Holt, B. van der","family":"Holt","given":"B. van der","role":"aut"},{"family":"Westveer","display":"Westveer, P.","given":"P.","role":"aut"},{"role":"aut","given":"Iris","family":"Breitkreutz","display":"Breitkreutz, Iris"},{"given":"Axel","role":"aut","family":"Benner","display":"Benner, Axel"},{"role":"aut","given":"A.","display":"Glasmacher, A.","family":"Glasmacher"},{"given":"I. G. D.","role":"aut","display":"Schmidt-Wolf, I. G. D.","family":"Schmidt-Wolf"},{"given":"H.","role":"aut","family":"Martin","display":"Martin, H."},{"given":"D.","role":"aut","family":"Hoelzer","display":"Hoelzer, D."},{"given":"Anthony Dick","role":"aut","display":"Ho, Anthony Dick","family":"Ho"},{"family":"Lokhorst","display":"Lokhorst, H. M.","given":"H. M.","role":"aut"}]} 
SRT |a GOLDSCHMIDJOINTHOVON4200